Stem Cell Assay Market: Trends, Opportunities and Competitive Analysis [2023-2028]
Stem Cell Assay Market Trends and Forecast
The future of the global stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes. The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028 with a CAGR of 19.1% from 2023 to 2028. The major drivers for this market are increasing awareness of the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Stem Cell Assay Market by Segment
The study includes trends and forecast for the global stem cell assay market by type, cell type, product & service, application, end use industry, and region, as follows:
Stem Cell Assay Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, stem cell assay companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stem cell assay companies profiled in this report include-
Q1. What is the stem cell assay market size?
Answer: The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028.
Q2. What is the growth forecast for stem cell assay market?
Answer: The global stem cell assay market is expected to grow with a CAGR of 19.1% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the stem cell assay market?
Answer: The major drivers for this market are increasing awareness about the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.
Q4. What are the major segments for stem cell assay market?
Answer: The future of the stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes.
Q5. Who are the key stem cell assay companies?
Answer: Some of the key stem cell assay companies are as follows:
Answer:Lucintel forecasts that viability/cytotoxicity assay will remain the largest segment over the forecast period due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.
Q7. In stem cell assay market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth during the forecast period due to the presence of well-established research infrastructure and increasing government initiatives for stem cell-based research in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1.What are some of the most promising, high-growth opportunities for the stem cell assay market by type (viability or cytotoxicity, isolation and purification, cell identification, proliferation, differentiation, function, apoptosis, and others), cell type (adult, mesenchymal, induced pluripotent, hematopoietic, umbilical cord, neural, human embryonic), product & service (instruments, flow cytometers, microelectrode arrays, cell imaging & analysis systems, automated cell counters, and kits services), application (regenerative medicine & therapy development, orthopedic, musculoskeletal, and spine application, dermatology application, cardiovascular application, CNS application, oncology application, diabetes application, drug discovery & development, and clinical research), end use industry (biopharmaceutical & biotechnology companies and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
For any questions related to stem cell assay market or related stem cell assay companies, stem cell assay market size, stem cell assay market share, stem cell assay analysis, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
The future of the global stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes. The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028 with a CAGR of 19.1% from 2023 to 2028. The major drivers for this market are increasing awareness of the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Stem Cell Assay Market by Segment
The study includes trends and forecast for the global stem cell assay market by type, cell type, product & service, application, end use industry, and region, as follows:
Stem Cell Assay Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Viability or Cytotoxicity
- Isolation and Purification
- Cell Identification
- Proliferation
- Differentiation
- Function
- Apoptosis
- Others
- Adult
- Mesenchymal
- Induced Pluripotent
- Hematopoietic
- Umbilical Cord
- Neural
- Human Embryonic
- Instruments
- Flow Cytometers
- Microelectrode Arrays
- Cell Imaging & Analysis Systems
- Automated Cell Counters
- Kits
- Services
- Regenerative Medicine & Therapy Development
- Orthopedic, Musculoskeletal, and Spine Application
- Dermatology Application
- Cardiovascular Application
- CNS Application
- Oncology Application
- Diabetes Application
- Drug Discovery & Development
- Clinical Research
- Biopharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, stem cell assay companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stem cell assay companies profiled in this report include-
- Thermo Fisher Scientific
- Merck KGaA
- Danaher
- Becton, Dickinson and Company
- Agilent Technologies
- Bio-Techne Corporation
- Lonza Group
- PerkinElmer
- Cell Biolabs
- Bio-Rad Laboratories
- Lucintel forecasts that viability/cytotoxicity assay will remain the largest type segment over the forecast period due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.
- Within this market, the biopharmaceutical & biotechnology companies segment is expected to record the highest growth due to growing prevalence of chronic diseases, an increase in the number of clinical trials, and growing strategic activities along with improvements in healthcare services.
- North America is expected to witness the highest growth during the forecast period due to the presence of well-established research infrastructure and increasing government initiatives for stem cell-based research in the region.
- Market Size Estimates: Stem cell assay market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Stem cell assay market size by various segments, such as by type, cell type, product & service, application, end use industry, and region
- Regional Analysis: Stem cell assay market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different by type, cell type, product & service, application, end use industry, and regions for the stem cell assay market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the stem cell assay market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q1. What is the stem cell assay market size?
Answer: The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028.
Q2. What is the growth forecast for stem cell assay market?
Answer: The global stem cell assay market is expected to grow with a CAGR of 19.1% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the stem cell assay market?
Answer: The major drivers for this market are increasing awareness about the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.
Q4. What are the major segments for stem cell assay market?
Answer: The future of the stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes.
Q5. Who are the key stem cell assay companies?
Answer: Some of the key stem cell assay companies are as follows:
- Thermo Fisher Scientific
- Merck KGaA
- Danaher
- Becton, Dickinson and Company
- Agilent Technologies
- Bio-Techne Corporation
- Lonza Group
- PerkinElmer
- Cell Biolabs
- Bio-Rad Laboratories
Answer:Lucintel forecasts that viability/cytotoxicity assay will remain the largest segment over the forecast period due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.
Q7. In stem cell assay market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth during the forecast period due to the presence of well-established research infrastructure and increasing government initiatives for stem cell-based research in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1.What are some of the most promising, high-growth opportunities for the stem cell assay market by type (viability or cytotoxicity, isolation and purification, cell identification, proliferation, differentiation, function, apoptosis, and others), cell type (adult, mesenchymal, induced pluripotent, hematopoietic, umbilical cord, neural, human embryonic), product & service (instruments, flow cytometers, microelectrode arrays, cell imaging & analysis systems, automated cell counters, and kits services), application (regenerative medicine & therapy development, orthopedic, musculoskeletal, and spine application, dermatology application, cardiovascular application, CNS application, oncology application, diabetes application, drug discovery & development, and clinical research), end use industry (biopharmaceutical & biotechnology companies and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
For any questions related to stem cell assay market or related stem cell assay companies, stem cell assay market size, stem cell assay market share, stem cell assay analysis, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL STEM CELL ASSAY MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Stem Cell Assay Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Stem Cell Assay Market by Assay Type
3.3.1: Viability or Cytotoxicity
3.3.2: Isolation and Purification
3.3.3: Cell Identification
3.3.4: Proliferation
3.3.5: Differentiation
3.3.6: Function
3.3.7: Apoptosis
3.3.8: Others
3.4: Global Stem Cell Assay Market by Cell Type
3.4.1: Adult
3.4.2: Mesenchymal
3.4.3: Induced Pluripotent
3.4.4: Hematopoietic
3.4.5: Umbilical Cord
3.4.6: Neural
3.4.7: Human Embryonic
3.5: Global Stem Cell Assay Market by Product & Service
3.5.1: Instruments
3.5.2: Flow Cytometers
3.5.3: Microelectrode Arrays
3.5.4: Cell Imaging & Analysis Systems
3.5.5: Automated Cell Counters
3.5.6: Kits
3.5.7: Services
3.6: Global Stem Cell Assay Market by Application
3.6.1: Regenerative Medicine & Therapy Development
3.6.2: Orthopedic, Musculoskeletal, and Spine Application
3.6.3: Dermatology Application
3.6.4: Cardiovascular Application
3.6.5: CNS Application
3.6.6: Oncology Application
3.6.7: Diabetes Application
3.6.8: Drug Discovery & Development
3.7: Global Stem Cell Assay Market by End Use Industry
3.7.1: Biopharmaceutical & Biotechnology Companies
3.7.2: Academic & Research Institutes
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Stem Cell Assay Market by Region
4.2: North American Stem Cell Assay Market
4.2.1: North American Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
4.2.2: North American Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
4.3: European Stem Cell Assay Market
4.3.1: European Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
4.3.2: European Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
4.4: APAC Stem Cell Assay Market
4.4.1: APAC Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
4.4.2: APAC Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
4.5: ROW Stem Cell Assay Market
4.5.1: ROW Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
4.5.2: ROW Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Stem Cell Assay Market by Assay Type
6.1.2: Growth Opportunities for the Global Stem Cell Assay Market by Cell Type
6.1.3: Growth Opportunities for the Global Stem Cell Assay Market by Product & Service
6.1.4: Growth Opportunities for the Global Stem Cell Assay Market by Application
6.1.5: Growth Opportunities for the Global Stem Cell Assay Market by End Use Industry
6.1.6: Growth Opportunities for the Global Stem Cell Assay Market by Region
6.2: Emerging Trends in the Global Stem Cell Assay Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Stem Cell Assay Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stem Cell Assay Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Thermo Fisher Scientific
7.2: Merck KGaA
7.3: Danaher
7.4: Becton, Dickinson and Company
7.5: Agilent Technologies
7.6: Bio-Techne Corporation
7.7: Lonza Group
7.8: PerkinElmer
7.9: Cell Biolabs
7.10: Bio-Rad Laboratories
2. GLOBAL STEM CELL ASSAY MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Stem Cell Assay Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Stem Cell Assay Market by Assay Type
3.3.1: Viability or Cytotoxicity
3.3.2: Isolation and Purification
3.3.3: Cell Identification
3.3.4: Proliferation
3.3.5: Differentiation
3.3.6: Function
3.3.7: Apoptosis
3.3.8: Others
3.4: Global Stem Cell Assay Market by Cell Type
3.4.1: Adult
3.4.2: Mesenchymal
3.4.3: Induced Pluripotent
3.4.4: Hematopoietic
3.4.5: Umbilical Cord
3.4.6: Neural
3.4.7: Human Embryonic
3.5: Global Stem Cell Assay Market by Product & Service
3.5.1: Instruments
3.5.2: Flow Cytometers
3.5.3: Microelectrode Arrays
3.5.4: Cell Imaging & Analysis Systems
3.5.5: Automated Cell Counters
3.5.6: Kits
3.5.7: Services
3.6: Global Stem Cell Assay Market by Application
3.6.1: Regenerative Medicine & Therapy Development
3.6.2: Orthopedic, Musculoskeletal, and Spine Application
3.6.3: Dermatology Application
3.6.4: Cardiovascular Application
3.6.5: CNS Application
3.6.6: Oncology Application
3.6.7: Diabetes Application
3.6.8: Drug Discovery & Development
3.7: Global Stem Cell Assay Market by End Use Industry
3.7.1: Biopharmaceutical & Biotechnology Companies
3.7.2: Academic & Research Institutes
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Stem Cell Assay Market by Region
4.2: North American Stem Cell Assay Market
4.2.1: North American Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
4.2.2: North American Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
4.3: European Stem Cell Assay Market
4.3.1: European Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
4.3.2: European Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
4.4: APAC Stem Cell Assay Market
4.4.1: APAC Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
4.4.2: APAC Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
4.5: ROW Stem Cell Assay Market
4.5.1: ROW Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
4.5.2: ROW Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Stem Cell Assay Market by Assay Type
6.1.2: Growth Opportunities for the Global Stem Cell Assay Market by Cell Type
6.1.3: Growth Opportunities for the Global Stem Cell Assay Market by Product & Service
6.1.4: Growth Opportunities for the Global Stem Cell Assay Market by Application
6.1.5: Growth Opportunities for the Global Stem Cell Assay Market by End Use Industry
6.1.6: Growth Opportunities for the Global Stem Cell Assay Market by Region
6.2: Emerging Trends in the Global Stem Cell Assay Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Stem Cell Assay Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stem Cell Assay Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Thermo Fisher Scientific
7.2: Merck KGaA
7.3: Danaher
7.4: Becton, Dickinson and Company
7.5: Agilent Technologies
7.6: Bio-Techne Corporation
7.7: Lonza Group
7.8: PerkinElmer
7.9: Cell Biolabs
7.10: Bio-Rad Laboratories
